Delivery Order SPE2DX22D0010-SPE2D826FAU48
Award Date 11/3/25
Potential Completion Date 11/4/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for Oxymorphone HCL ER Tablets 20mg, valued at $11,664.15 under a firm fixed-price contract type. This non-competitive delivery order represents a single-item pharmaceutical procurement with an ultimate completion date of August 21, 2025. The award was made without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Oxymorphone HCL ER Tablets 20mg, a controlled-release pain management pharmaceutical. This non-set-aside, competitively awarded delivery order has a ceiling value of $15,791.14 and a firm fixed-price structure, with an ultimate completion date of September 18, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for Oxymorphone HCL ER Tablets 15mg, with a ceiling value of $1,404.26 and an ultimate completion date of August 25, 2025. This non-competitive, firm fixed-price delivery order represents a pharmaceutical procurement under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $1 billion...
- On June 16, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Oxymorphone HCL ER Tablets 15mg, with a ceiling value of $1,404.26. This competitively awarded, non-set-aside contract is structured as a firm fixed-price delivery order and is scheduled for completion by June 17, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- AmerisourceBergen Drug Corp was awarded a delivery order on October 22, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Oxymorphone HCL ER Tablets 20mg with a ceiling value of $5,773.98. This is a firm fixed-price delivery order with an ultimate completion date of October 23, 2025, and represents a non-competitive set-aside award. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- On September 25, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $8,331.03 to AmerisourceBergen Drug Corp for the supply of Oxymorphone HCL ER Tablets 10mg. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. Performance of this order is scheduled for completion by September 26, 2025, at AmerisourceBergen's corporate office location in...
- This delivery order, awarded on August 13, 2025, by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, provides Oxymorphone HCL ER Tablets 40mg with a ceiling value of $2,062.57. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 14, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $7,311.06 on September 22, 2025, for the supply of Oxymorphone HCL Extended Release tablets (20mg) under a Firm Fixed Price contract with the Defense Logistics Agency's Medical Supply Chain. The contract is a non-set-aside award issued through competitive procurement and carries an ultimate completion date of September 23, 2025. Performance will be executed from the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Oxymorphone HCL ER 20 mg tablets in quantities of 60 units, with a contract ceiling value of $1,216.15. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and represents a non-competitive set-aside contract. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,990.02 on August 6, 2025, for the supply of Oxymorphone HCL ER Tablets 20mg to the Defense Logistics Agency's Medical Supply Chain. The contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025. This delivery order...